Medistim ASA
LSE:0OCD

Watchlist Manager
Medistim ASA Logo
Medistim ASA
LSE:0OCD
Watchlist
Price: 250.5 NOK 1.83%
Market Cap: kr51.2m

Wall St Price Targets

0OCD Price Forecast
Based on 3 analysts

+36% Upside
from kr250.5 today

Medistim ASA (0OCD)’s 12-month stock price forecast through September 2027 has a consensus target of kr340.53, implying 36% upside. The forecast is based on price targets from 3 Wall Street analysts.

0OCD Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for 0OCD yet.

Medistim ASA Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0OCD's stock price target?
Price Target
340.53 NOK

According to Wall Street analysts, the average 1-year price target for 0OCD is 340.53 NOK with a low forecast of 329.58 NOK and a high forecast of 358.45 NOK.

What is the Revenue forecast for Medistim ASA?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 11%.

What is the Gross Profit forecast for Medistim ASA?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 11%.

What is the Operating Income forecast for Medistim ASA?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 11%.

What is the Pre-Tax Income forecast for Medistim ASA?
Projected CAGR
45%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next -1 years is 45%.

What is the Net Income forecast for Medistim ASA?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is 8%.

Back to Top